National Institute for Communicable Disease Control and Prevention

Facility Details

Region Western Pacific

GLP Lead WHO

GLP Compliance Progress

Status 1. Site Development

GLP Compliance Target 2019 Q4

Product Testing

IRS

Lab Trials (Phase I)
Small Scale Trials (Phase II)
Small Scale Trials (Phase III)

LLINS

Lab Trials (Phase I)
Small Scale Trials (Phase II)
Small Scale Trials (Phase III)

SPACE SPRAYS

Lab Trials (Phase I)
Small Scale Trials (Phase II)
Small Scale Trials (Phase III)

LARVICIDES

Lab Trials (Phase I)
Small Scale Trials (Phase II)
Small Scale Trials (Phase III)

TOPICAL REPELLENTS

Lab Trials (Phase I)
Small Scale Trials (Phase II)
Small Scale Trials (Phase III)

GENETICALLY MODIFIED MOSQUITOES

Lab Trials (Phase I)
Small Scale Trials (Phase II)
Lab Trials (Phase I)

Capacity and Features

Number of huts 0

Style of Huts TBC

Any Other Facilities TBC

Laboratory Strains
- Strain Names & Species

An.sinensis (SS);
Cx. pipiens pallens (3 strains: 2 SS, 1 RR;
Cx. tritaeniorhynchus (SS);
Ae. aegypti (SS);
Ae. albopictus (SS).

Wild Populations (and Resistance Profiles) - Species

Aedes aegypti (2 strains);
Aedes albopictus (3 strains).

Hut testing possible in the following months of the year

We do not currently have confirmation on this facilities time-of-year capabilities. Please use contact details below and a relevant contact will be able to support further.

Village Scale Trials possible in the following months of the year

We do not currently have confirmation on this facilities time-of-year capabilities. Please use contact details below and a relevant contact will be able to support further.

Contact Details

Contact Liu Qiyong

Phone Number TBC

Email Address liuqiyong@icdc.cn

Website http://www.chinacdc.cn